August 27, 2025 - 20:06

Lakshmi Singh, a clinical pharmacist at the Veterans Affairs Medical Center in Hampton, Virginia, is revolutionizing diabetes care for veterans through the use of cutting-edge technology. By integrating advanced digital tools into diabetes management, Singh is not only improving health outcomes but also enhancing the quality of life for veterans like Andrew Francis and Howard Carney.
The initiative focuses on personalized care plans that leverage mobile applications and telehealth services, allowing veterans to monitor their blood sugar levels more effectively. Singh emphasizes the importance of education and empowerment, guiding veterans to take control of their health through technology. This approach enables them to track their diet, exercise, and medication adherence in real time.
Veterans often face unique challenges in managing chronic conditions like diabetes, and Singh's innovative strategies aim to bridge the gap in healthcare access. With the support of modern technology, veterans are better equipped to navigate their health journeys, leading to improved management of diabetes and overall well-being.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...